Cefoperazone + Sulbactam Injection
ADWIFT – S is a anti-infective combination of Cefoperazone + Sulbactam in which cefoperazone is a commonly used broad-spectrum semi-synthetic third-generation cephalosporin with a potent bactericidal activity against a wide range of gram-positive and gram-negative bacteria and Sulbactam is B – lactamase inhibitor.
  • Bacteremia / Septicemia
  • ICU infections
  • Complicated skin and soft tissue infections
  • Gynecological infections
  • Product variants & features
     Product  Strength  Presentation  Features
    ADWIFT–S  1 gm

    2 gm  
    1 gm, 2 gm available in Glass vial with SWFI  
    • The peak plasma concentration following 1gm I.V. administration : 65 mcg/ mg.
    • Serum protein binding: 82% to 93%
    • Cefoperazone crosses the placenta.
    • Excreted principally in bile. Following IM or IV administration of a single dose of cefoperazone, approximately 15 – 30% of the dose is excreted in urine as unchanged drug; less than 1% of the dose is excreted in urine as metabolites.
    • Sulbactam is ß– lactamase inhibitor  

    Claris Lifesciences Ltd. All Rights Reserved.  :: Terms of Use  ::Privacy Policy ::Sitemap